Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Pediatría | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 2
ClinicalTrials.gov
An Open-Label, Multicenter Phase 2 Basket Study to Evaluate the Antitumor Activity and Safety of Lenvatinib in Children, Adolescents, and Young Adults With Relapsed or Refractory Solid Malignancies
INTERVENTIONAL
Inicio: 30 de jul de 2020
ID: NCT04447755
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Observer-Blinded, Active-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Ceftaroline Versus Ceftriaxone in Pediatric Subjects With Community-acquired Bacterial Pneumonia Requiring Hospitalization
INTERVENTIONAL
Inicio: 1 de sept de 2012
ID: NCT01530763
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled Induction and Maintenance Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Subjects With Eosinophilic Esophagitis
INTERVENTIONAL
Inicio: 22 de feb de 2021
ID: NCT04753697
Completado
Fase 3
ClinicalTrials.gov
A Prospective, Open-Label, Active-Controlled Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Rivaroxaban for Thromboprophylaxis in Pediatric Subjects 2 to 8 Years of Age After the Fontan Procedure
INTERVENTIONAL
Inicio: 16 de nov de 2016
ID: NCT02846532
Reclutando
Fase 3
ClinicalTrials.gov
A Phase III Study to Evaluate the Efficacy of INM004 (Shiga Antitoxin) in Pediatric Patients With Shiga Toxin-producing Escherichia Coli-associated Hemolytic Uremic Syndrome.
INTERVENTIONAL
Inicio: 5 de oct de 2024
ID: NCT06389474
Reclutando
Fase 3
ClinicalTrials.gov
16-Week Randomized Double-Blind Placebo Controlled Parallel-Group Multicenter Study Evaluating the Efficacy and Safety of OPN-375 186 μg Twice a Day in Adolescents With Bilateral Nasal Polyps Followed With 12-Week Open-Label Treatment Phase
INTERVENTIONAL
Inicio: 31 de dic de 2018
ID: NCT03747458
Activo, no recluta
Fase 3
ClinicalTrials.gov
Multicenter, Open-label, Efficacy, Safety, Tolerability, and Pharmacokinetic Study of Subcutaneous Ixekizumab With Adalimumab Reference Arm, in Children With Juvenile Idiopathic Arthritis Subtypes of Enthesitis-related Arthritis (Including Juvenile-Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
INTERVENTIONAL
Inicio: 13 de abr de 2021
ID: NCT04527380
Completado
Fase 2
ClinicalTrials.gov
Continued Access to DRV/Rtv in HIV-1 Infected Children and Adolescents (Rollover Patients From C212, C228, C230)
INTERVENTIONAL
Inicio: 13 de oct de 2010
ID: NCT01138605
Completado
Fase 2
ClinicalTrials.gov
A Phase II Study to Assess Safety, Efficacy, and Pharmacokinetics of INM004 (Anti-Shiga Toxin) in Pediatric Patients With Hemolytic Uremic Syndrome Associated With Shiga Toxin-producing Escherichia Coli Infection
INTERVENTIONAL
Inicio: 6 de oct de 2022
ID: NCT05569746
Activo, no recluta
Fase 2
ClinicalTrials.gov
A 52-week Randomized, Double-blind, Placebo-controlled, Multi-center Phase 2a Study Assessing Safety and Efficacy of Brivekimig, a Dual Anti-TNF-α and Anti-OX40L NANOBODY® Molecule, for Preservation of Pancreatic β-cell Function in Adults and Adolescents With Recently Diagnosed Type 1 Diabetes
INTERVENTIONAL
Inicio: 28 de feb de 2025
ID: NCT06812988
Completado
Fase 1
ClinicalTrials.gov
Long-Term Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Tocilizumab in Patients With Polyarticular-Course and Systemic Juvenile Idiopathic Arthritis
INTERVENTIONAL
Inicio: 16 de jul de 2014
ID: NCT02165345
Reclutando
Fase 3
ClinicalTrials.gov
Open-Label, Randomized Study With a Tocilizumab Reference Arm to Evaluate Safety, Efficacy and Pharmacokinetics of Baricitinib in Children From 1 to Less Than 18 Years of Age With Systemic Juvenile Idiopathic Arthritis.
INTERVENTIONAL
Inicio: 12 de feb de 2020
ID: NCT04088396
Completado
ClinicalTrials.gov
A Screening Protocol to Assess Adult and Adolescent Individuals With Down Syndrome for Eligibility to Participate in an Upcoming Study to Evaluate the Efficacy, Safety and Tolerability of RG1662 (Study BP27832)
OBSERVATIONAL
Inicio: 31 de oct de 2013
ID: NCT01920633
Completado
Fase 2
ClinicalTrials.gov
Prospective, Parallel-group, Open-label Randomized Controlled Trial of Four Treatment Regimes for Trichuriasis in Pediatric Patients
INTERVENTIONAL
Inicio: 9 de oct de 2019
ID: NCT04041453
Completado
Fase 3
ClinicalTrials.gov
Prospective, Historically Controlled Study to Evaluate the Efficacy and Safety of a New Pediatric Formulation of Nifurtimox in Children Aged 0 to 17 Years With Chagas' Disease
INTERVENTIONAL
Inicio: 27 de ene de 2016
ID: NCT02625974
Completado
Fase 3
ClinicalTrials.gov
Multicenter, Open-label Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LCZ696 Followed by a 52-week Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared With Enalapril in Pediatric Patients From 1 Month to < 18 Years of Age With Heart Failure Due to Systemic Left Ventricle Systolic Dysfunction
INTERVENTIONAL
Inicio: 3 de nov de 2016
ID: NCT02678312
Completado
ClinicalTrials.gov
Treatment Protocol of the Third International Study For Langerhans Cell Histiocytosis
INTERVENTIONAL
Inicio: 1 de abr de 2001
ID: NCT00276757
Activo, no recluta
ClinicalTrials.gov
Prospective, Observational, Longitudinal Study in Pediatric Patients With Moderate to Severe Atopic Dermatitis Whose Disease is Not Adequately Controlled With Topical Prescription Therapies or When Those Therapies Are Not Medically Advisable
OBSERVATIONAL
Inicio: 15 de ago de 2019
ID: NCT03687359
Completado
Fase 3
ClinicalTrials.gov
A Multi-center, Randomized, Double-blind, Active and Placebo-controlled Study to Investigate the Efficacy and Safety of Ligelizumab (QGE031) in the Treatment of Chronic Spontaneous Urticaria (CSU) in Adolescents and Adults Inadequately Controlled With H1-antihistamines
INTERVENTIONAL
Inicio: 20 de oct de 2018
ID: NCT03580356
Completado
Fase 4
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Evaluate the Effects of a One-Year Course of Fluticasone Furoate Nasal Spray 110mcg QD on Growth in Pre-Pubescent, Pediatric Subjects With Perennial Allergic Rhinitis
INTERVENTIONAL
Inicio: 26 de nov de 2007
ID: NCT00570492
Anterior
1
...
14
15
16
...
434
Siguiente
Filtros